US Patent Issued to Eurofins Genomics Europe Sequencing, Genedata, UCL Business on Aug. 19 for "Epigenetic markers and related methods and means for the detection and management of certain cancers" (German, British, Swiss, Austrian Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,995, issued on Aug. 19, was assigned to Eurofins Genomics Europe Sequencing GmbH (Constance, Germany), Genedata AG (Basel, Switzerland) and UCL Business Ltd. (London).

"Epigenetic markers and related methods and means for the detection and management of certain cancers" was invented by Martin Widschwendter (Wildermieming, Austria), Allison Jones (London), Iona Evans (London), Harri Lempiainen (Binningen, Switzerland), Johannes Eichner (Lorrach, Germany), Tamas Rujan (Oberwil, Switzerland), Timo Wittenberger (Constance, Germany), Tobias Paprotka (Leipzig, Germany) and Benjamin Lindner (Laupheim, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "...